When two U.S. doctors went to Germany last summer to check on reports that a new chemical was showing promise in treating tuberculosis, they got an eye-opener. The drug had passed the promising stage, had shown impressive results over a two-year period in the treatment of 7,000 patients. And behind its discovery and development was the potent name of Professor Gerhard Domagk, 54, who won fameand a 1939 Nobel Prize, which the Nazis would not let him takeas top man in perfecting the sulfa drugs.
The drug was Tibione.-The U.S. investigators were Dr. H....
To continue reading:
or
Log-In
